Capital Fund Management (CFM)’s Editas Medicine EDIT Stock Holding History

Capital Fund Management (CFM)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,700	Closed	-$361K	–	1609
2022 Q4	$361K	Sell	40,700 -20,200	-33%	-$222K	﹤0.01%	1316
2022 Q3	$745K	Sell	60,900 -23,100	-28%	-$360K	0.01%	1168
2022 Q2	$994K	Buy	84,000 +2,600	+3%	+$34.8K	0.01%	1073
2022 Q1	$1.55M	Buy	81,400 +12,800	+19%	+$238K	0.01%	1038
2021 Q4	$1.82M	Buy	+68,600	New	+$2.36M	0.01%	1072
2018 Q2	–	Sell	-52,600	Closed	-$1.74M	–	2050
2018 Q1	$1.74M	Buy	+52,600	New	+$1.87M	0.01%	1053

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s EDIT Position: Q3 2023 in Review

Capital Fund Management (CFM) sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 158,647 shares — an estimated $1.31M sold.

Capital Fund Management (CFM) first reported a position in EDIT in Q3 2018 and held it in 13 quarters. The position peaked at $6.99M in Q1 2022. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

Capital Fund Management (CFM) reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
Capital Fund Management (CFM) sold 158,647 Editas Medicine shares in Q3 2023, an estimated $1.31M.
Capital Fund Management (CFM) first reported a position in Editas Medicine in Q3 2018 and held it in 13 quarters.
Capital Fund Management (CFM)'s Editas Medicine position peaked at $6.99M in Q1 2022.
220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2023, filed 14 Nov 2023.